Elixinol Wellness (ASX:EXL) Cash-to-Debt : 0.56 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Elixinol Wellness's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.56.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Elixinol Wellness couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Elixinol Wellness's Cash-to-Debt or its related term are showing as below:

ASX:EXL' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.56 Med: 4.51 Max: 171.69
Current: 0.56

During the past 6 years, Elixinol Wellness's highest Cash to Debt Ratio was 171.69. The lowest was 0.56. And the median was 4.51.

ASX:EXL's Cash-to-Debt is ranked worse than
59.58% of 1002 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs ASX:EXL: 0.56

Elixinol Wellness Cash-to-Debt Historical Data

The historical data trend for Elixinol Wellness's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Elixinol Wellness Cash-to-Debt Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

4.36

10.14

4.66

1.50

0.56

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial							4.66	3.32	1.50	2.36	0.56

Competitive Comparison of Elixinol Wellness's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Cash-to-Debt falls into.

Elixinol Wellness Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Elixinol Wellness's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.708	/	(1.07	+	0.192)
	=	0.56

Elixinol Wellness's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.708	/	(1.07	+	0.192)
	=	0.56

Elixinol Wellness (ASX:EXL) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Elixinol Wellness Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines